HIV PREVENTION in VULNERABLE POPULATIONS: GENERATING EVIDENCE to REDUCE INEQUALITIES
Topics in Antiviral Medicine
; 30(1 SUPPL):3-4, 2022.
Article
in English
| EMBASE | ID: covidwho-1880298
ABSTRACT
The HIV epidemic in Latin America remains concentrated in large urban centers, with vulnerable populations suffering the highest burden, particularly MSM and transgender women. In the last 10 years, the number of new HIV infections remained high and stable, and although ART coverage led to a significant decrease in AIDS-related mortality, the decrease was lower in Latin America when compared to the other regions. Brazil accounts for more than one-third of the HIV burden of the region. It was the first low-/middle-income country to provide access to universal treatment to individuals living with HIV. Brazil's actions towards the AIDS crisis assumed a human rights-based approach, integrating both prevention and treatment efforts into its universal health care system. Brazil's civil society organizations play a crucial role in shaping the initial and ongoing response. Since 2014, a "Treat All" policy of providing antiretroviral treatment in addition to comprehensive services including HIV testing and laboratory monitoring, and pre-exposure prophylaxis has been in place. The impact of the policies on people living with HIV resulted in an improved quality of life and a decline in overall morbidity and mortality. Nonetheless, important challenges remain, including a high and stable HIV incidence among key populations, and a high prevalence of late treatment initiation and of early mortality from AIDS causes, impacting the multiple steps of the continuum of care. This presentation will (a) present recent epidemiologic data on the HIV epidemic in Latin America, (b) describe and detail the characteristics of the Brazilian response to the HIV epidemic and the current status of the epidemic in Brazil, and (c) share Brazil's contribution to cutting edge AIDS research and its impact on public health policies. The latter will focus on how the data emanating from research efforts have contributed to major innovations for the HIV prevention and care agenda. Areas highlighted include pMTCT, tuberculosis, ART strategies for treatment and prevention including pre-exposure prophylaxis, and vulnerable populations, particularly young MSM and transgender women, HPV, reproductive health, and COVID-19. These research advances were only made possible through close engagement with the community. It is through this strong community engagement that we aim to reduce stigma and discrimination while promoting human rights.
antiretrovirus agent; acquired immune deficiency syndrome; adult; Brazil; conference abstract; controlled study; coronavirus disease 2019; epidemic; female; HIV test; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; human rights; incidence; laboratory based surveillance; middle income country; morbidity; mortality; organization; pre-exposure prophylaxis; prevalence; public health; quality of life; reproductive health; South and Central America; stigma; transgender; tuberculosis; universal health care; vulnerable population
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Topics in Antiviral Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS